WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index

B SHANGHAI, May 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its…
posteditor
posteditor
Articles: 17424

Other News